Healthcare organizations face a more complicated search challenge as patients increasingly encounter information through traditional search, AI-generated answers and emerging discovery interfaces. KSMModel.ai and PeptideDoc.com are putting that challenge under measurement with a 90-day case study designed to track how a healthcare practice becomes more understandable, recognizable and citable to search engines and generative AI systems.

The study uses KSMModel.ai's Knowledge Structuring Model (KSM) to measure PeptideDoc's digital presence at four checkpoints: Day 1, Day 30, Day 60 and Day 90. Rather than treating AI visibility as a single ranking metric, the framework evaluates three components: Structured Extractability, Entity Salience and Citation Authority.

The distinction is important because being indexed does not necessarily mean an organization will be accurately represented by an AI system.

For a healthcare practice, an AI platform needs to establish several relationships: who operates the practice, which physician is associated with it, where the practice is located, which services it provides and whether independent sources corroborate those claims.

KSMModel.ai describes its formula as AI Visibility = f(Structured Extractability × Entity Salience × Citation Authority). In practical terms, the model asks whether machines can extract the organization's information, connect the correct entities and find sufficient independent evidence to reinforce those connections.

PeptideDoc entered the implementation with a pre-launch KSM score of 35/100. Its formal Day 1 assessment reached 62/100, a 27-point increase. KSMModel.ai has frozen that 62-point result as the study's baseline, meaning subsequent improvements will be assessed at the 30-, 60- and 90-day checkpoints rather than being added retroactively.

The first phase focused heavily on technical and structural clarity. PeptideDoc's organization, physician, services and location information were made more consistent, while priority pages received revised metadata, canonical signals, indexing controls and structured data.

The resulting relationship is designed to be explicit: Saul F. Maslavi, MD → Founder & Owner → PeptideDoc → Bayside, Queens → physician-led medical services.

That approach aligns with how search engines already encourage organizations to make information machine-readable. Google says structured data provides explicit clues about the meaning of a page and can help its systems understand content.

The study also reported an early indexing improvement. A priority PeptideDoc service page that had previously been flagged as unavailable for indexing in Bing Webmaster Tools became eligible for indexing following remediation.

The more difficult phase now begins.

Technical SEO can make information accessible, but healthcare visibility also depends on whether external sources reinforce the same facts. PeptideDoc's study therefore looks at health-system profiles, insurer directories, professional registries, Google Business Profile information, external mentions and other sources that can corroborate the physician-practice relationship.

That emphasis on external authority is becoming increasingly relevant as AI search develops. Gartner's 2026 research describes AEO and GEO as extensions of search strategy for environments where AI systems influence discovery, while emphasizing that organizations need visibility across both traditional and AI-powered search.

Google's own 2026 guidance similarly says traditional SEO fundamentals remain important for appearing in its generative AI search experiences, while recommending valuable, original content rather than attempting to optimize exclusively for AI systems.

For healthcare marketers, the implication is broader than rankings. An AI system that retrieves the wrong physician, mismatches a location or confuses services can create a much more serious problem than a conventional search-result drop.

That makes entity SEO, structured data and citation authority particularly consequential in healthcare. The KSM study is notable because it attempts to measure those factors over time rather than presenting a one-time optimization result.

The Day 90 outcome will ultimately be more informative than the Day 1 improvement. The critical question is whether better structure translates into sustained recognition, accurate entity relationships and independent citations across search and generative AI platforms.

Market Landscape

AI search is creating a new layer of visibility management for brands. Gartner has identified a growing market for answer-engine visibility tools, noting that marketers increasingly need to account for LLM-powered search in discovery and purchase journeys.

Healthcare makes the problem especially sensitive because the information being surfaced can involve physicians, medical services, locations and professional credentials.

The market is consequently moving beyond conventional keyword optimization toward a combination of technical SEO, AEO, GEO, entity management, structured data and digital authority. But this does not mean traditional SEO has become obsolete. Gartner says marketers should integrate SEO, AEO and GEO rather than treat them as separate strategies.

Google has made a similar point, stating that its established search fundamentals continue to underpin visibility in generative AI experiences.

For healthcare organizations, the emerging competitive advantage may therefore come from making authoritative information both machine-readable and independently verifiable.

Strategic Outlook

The PeptideDoc study illustrates an important transition in digital marketing: AI visibility is becoming measurable as an ongoing business capability rather than a one-time SEO project.

The KSM framework's three-part structure is particularly useful as an analytical model because it separates technical accessibility from entity recognition and external authority. A site can be technically excellent while still lacking enough independent evidence for an AI system to confidently associate a business, physician and service.

The next 90 days will test whether PeptideDoc's improved digital structure produces measurable external recognition. If it does, the case could provide a useful framework for healthcare marketers evaluating AI search readiness beyond conventional rankings and traffic.

Top Insights

• PeptideDoc's 62/100 frozen baseline creates a measurable AI visibility benchmark, allowing later changes in search and AI recognition to be evaluated without retroactive scoring.
• KSM separates technical accessibility from entity recognition and authority, addressing three distinct problems healthcare organizations face when appearing in AI-generated answers.
• Healthcare demands stronger entity accuracy than ordinary SEO, because AI systems must correctly associate physicians, practices, locations, services and credentials.
• External citations become increasingly important in AI search, helping systems independently corroborate organizational claims instead of relying solely on first-party website content.
• The 90-day study tests whether technical SEO improvements translate into AI recognition, providing a more meaningful measure than short-term changes in conventional search visibility.

Get in touch with our MarTech Experts.